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1. Introduction 
The placenta is a transient organ responsible for maternal fetus nutrient and oxygen 
exchange. It is important to the modulation of the maternal immune response to antigens of 
paternal and fetal origin and a source of a great variety of hormones that ensure the 
maintenance of gestation. Pathological conditions of pregnancy, fetal growth and delivery, 
abnormal placentation and surgical problems always attracted the medical sciences 
attention. The diversity of placental types among eutherian mammals has often raised 
important questions about phylogeny. In vitro culture of placental cells is an approach that 
allows the investigation of hormonal production and metabolic process as well as 
pathological disorders of common occurrence in human beings and animals. This chapter 
aims to show the most important features on culturing placenta derived cells and cell 
populations with properties of progenitor/stem cells: identification of the structures, 
isolation of the cells, maintenance of the cell culture, and applicability in research trends. 
2. The placenta 
Retention and development of the fertilized egg within the maternal body (histotrophic and 
hemotrophic viviparity) are observed in most mammals, reptiles and a few lower 
organisms. The growing embryo is nourished by the mother, usually through a placenta or 
similar structure. Vertebrate viviparity with the development of a placenta in the uterus 
evolved 150-100 million years ago and is responsible for the adaptability and dispersion of 
eutherian mammalians all over the diverse habitats.  
The Mammalian class is divided into two subclasses, Prototheria and Theria, which includes 
the two major groups of viviparous mammals, the marsupials and placentals.  
Four superorders of eutherian mammals were identified by techniques of molecular 
phylogenetics. The two oldest superorders Afrotheria (elephants and others) and Xenarthra 
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(armadillos, anteaters and sloths) have either endothelial or hemochorial placentas. 
Members of the superorder Euarchontoglires exhibit hemochorial placentas (Glires – 
rodents and lagomorphs) and endotheliochorial placentation (Euarchonta – tree shrews). 
Epitheliochorial placentas are observed in the last superorder to arise, the Laurasiatheria 
(horses, ruminants and various other species). It seems that the likely path of evolution in 
Afrotheria was from endotheliochorial to hemochorial placentation and the same condition 
apparently occurs with the Xenarthra and the bats. It is possible that endotheliochorial 
placentation was the more primitive and that epitheliochorial placenta evolved twice, once 
in the Laurasiatheria and once in Euarchontoglires. Mammalian phylogeny has been 
extensively studied (1–4). 
The placenta should be considered as an apposition of the fetal membranes to the uterine 
tissue for physiological exchange, and in mammals the definitive placentation is of the 
chorio-allantoic type, in which mesodermal blood vessels, from the allantoids external layer, 
form a vascular bridge between the embryo and the chorion, allowing a broad 
vascularization, and increasing efficiency in the mother-fetus exchange (5). In this situation, 
the maternal-fetal interface is enlarged, because chorionic villous fills the uterine crypts. In 
the chorion-vitelline placenta, there is a fusion between the yolk sac and its blood vessels 
network with the chorion. Here the allantois is never in contact with the chorion and it is 
observed in some non-mammalian vertebrates. In mammalian species, however, it occurs 
temporarily, while the allantois is developing from the intestine, to constitute the chorio-
allantoic placenta.  
Despite of all the work to develop systems of classification and to use placental structure to 
aid in the investigation of phylogenetic relationships among species of different orders, 
there is a lack of morphological and electron microscopic studies of the placenta in a great 
number of organisms, limiting the efforts to generalizations. The classical systems of 
classification of the placenta, based on structure, are of limited significance. Considering 
that the trophoblast could be apposed to uterine ephithelium, to the endothelium of 
maternal vessels or directly to maternal blood, the placenta is classified as epitheliochorial, 
endotheliochorial or hemochorial, respectively. However, electron microscopy studies have 
been shown that a continuous fetal endothelium and chorion always persist, although very 
thin in some tissue extensions, reducing the diffusion distance between fetal and maternal 
circulation, even in epitheliochorial placentas. 
It is now well recognized that the number of layers between fetal and maternal circulation 
do not have any relationship to the placenta’s ability to supply oxygen to the fetus. 
Interhaemal area is reduced in many ways in the different types of placentation. In the 
ruminant’s placenta (epitheliochorial and synepitheliochorial) the indentation of trophoblast 
and uterine epithelium by blood vessels decreases the interhaemal distance; in the 
endotheliochorial placentae this reduction is achieved by the indentation of trophoblast by 
fetal capillaries within the labyrinth. In the haemochorial placentation several features occur 
to reduce the thickness of the trophoblast, like alternation of thick and thin regions in the 
rabbit placenta (See (6) for detailed information).  
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The placenta developed as an organ to nutrient and oxygen exchange between the mother 
and fetus and also to avoid immunological rejection by the maternal immune system. Cells 
from the mother and the fetus intermingle throughout gestation and the extension of 
trophoblast invasion apparently is related to the modulation of maternal immune response 
against the allogenic conceptus (7). In the epithelialchorion placentation there are minimal 
changes in the uterine mucosa during gestation, whereas in the haemochorial placentation 
the endometrium is differentiated into decidua. These changes allow the establishment and 
maintenance of pregnancy and fetal survival with great diversity among different species. 
2.1. Organogenesis 
At the beginning of the mammalian development, the conceptus differentiates into an inner 
cell mass and an outer layer of cells, the trophoblast, which solely contributes to extra-
embryonic membranes formation (4,8). The tissue on the maternal component of the 
placenta usually is of epithelial or connective tissue origin of the ovary, oviduct or uterus. 
The fetal component is a derivate of ectodermal epithelium, the trophoblast or 
trophectoderm. 
Diverse populations of trophoblasts, all derived from the embryonic trophectoderm, have 
morphological, functional and molecular diversity within and across species. The extra-
embryonic membranes of the vertebrate conceptus form from the three germ layers of the 
embryo - the endoderm, mesoderm and ectoderm. These germ layers form the yolk sac, 
initially a single layer of ectoderm that is progressively transformed in a bilaminar and 
trilaminar structure, after the migration of a layer of endoderm internal to the ectoderm, and 
a growth of mesoderm between these two first layers. In mammals, the growth of mesoderm 
transforms only the superior part of the bilaminar yolk sac into the trilaminar vascularized 
structure, which is the basis for development of the chorion, amnion and allantois. Fusion of 
mesoderm and endoderm vascularizes promptly, whereas mesoderm and trophectoderm 
rarely form bloof vessels. The vascularized yolk sac fused with the ectoderm form the fetal 
component of the choriovitelline placenta, and the vascularized allantois plus chorion forms 
the fetal part of the chorioallantoic placenta. 
The trophectoderm and the inner cell mass become separate during early gestation and non 
interconvertible cell lineages. In mouse, for instance, Cdx2 is expressed predominantly in the 
trophoblast and Oct3/4 only in the inner cell mass (6). In the human placenta (9), the cell types 
that constitute placental villi are different populations of trophoblasts, the 
syncytiotrophoblasts and cytotrophoblasts that cover the surface of villi and bathe in maternal 
blood within intervillous space. Trophoblasts are formed during the first stage of pregnancy 
and are the first cells to differentiate from the fertilized egg. They have two cell populations, 
the undifferentiated cytotrophoblasts and fully differentiated syncytiotrophoblasts. The 
syncytiotrophoblasts are a continuous, specialized layer of epithelial cells.  
Mesenchymal cells, Hofbauer cells (mesenchymal derived macrophages) and fibroblasts are 
found between fetal vessels and trophoblasts in human species. The last group of cells is 
fetal vascular cells (vascular smooth muscle cells, endothelial and perivascular cells 
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(pericytes). Hofbauer cells are the macrophages in the placenta villous stroma. These cells 
are of mesenchymal origin and expand during the first and second trimesters in placental 
villous tissues mesenchymal stem cells are differentiated by vasculogenesis and 
angiogenesis, transform into hemangioblastic cell cords, which are believed to be the 
precursors of capillary endothelial cells and hematopoietic stem cells. Mesenchymal stem 
cells can also differentiate into perivascular cells, which are considered predecessors of 
capillary endothelial cells. Pericytes (perivascular cells with dendritic processes) are found 
surrounding capillary endothelium and venules. They support endothelial cells and are 
important for maintaining vessel stability and microvascular integrity. 
In mouse, the trophectoderm differentiates in two pathways: rapid proliferation of polar 
trophoblastic cells originate the extraembrionic ectoderm and the ectoplacental cone; and 
the mural trophoblastic cells that originate the primary giant trophoblastic cells by 
endoreplicating their DNA but not dividing, like in other rodent giant cells. These cells, 
however, are not analogous to that observed in the human placenta, despite bearing the 
same name. 
Chorionic binucleate cells are observed in the ruminant and horse placentas (6). In the mare, 
these are migratory transient cells and never fuse with maternal cells. In the cow and ewe, 
nevertheless, this population of fetal cells migrates through the chorionic tight junction to 
fuse with uterine epithelial cells throughout gestation. These cells are derived from 
uninucleate trophectoderm cells by consecutive nuclear divisions, the second without 
subsequent cytokinesis. The chorionic binucleate cells comprise 15 to 20 per cent of the 
trophectoderm epithelial cells and produce a great variety of hormones. This is a unique 
feature of the ruminant placenta. 
2.2. Structure and classification  
Placenta has been described in the early studies (5) as more variable in structure than any 
other mammalian organ, and consequently it is classified in different ways, but other 
classification (10), which distinguishes the layers between fetal trophoblast and maternal 
endometrial surface, is considered the most useful, despite its limitations regarding 
biological and evolutionary aspects, as it was mentioned before.  
Morphologically, the placenta is classified according to the configuration of the maternal-
fetal interface. The area of fetomaternal exchange is increased by the formation of placental 
folds (villi) which is characteristic among families. Four types of placenta are described: in 
the diffuse placenta (horse and pig) the allantochorion is involved in the formation of the 
organ and it is almost entirely in contact with the endometrium; the cotyledonary placenta, 
observed in ruminants, shows multiple and discrete areas of attachment to the 
endometrium. The fetal portion is called cotyledon and the maternal contact sites are the 
caruncles. The hemotrophic structures formed by this fusion are called placentomes.  
The placenta seen in carnivores like dogs and cats is called zonary, and the chorionic villi 
occupy the equatorial region of the chorionic sac, where they attach to the endometrium; 
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finally, a discoid placenta is present in rodents and primates, in which an area of the chorion 
(discoid in shape) adhere to the endometrial stroma.  
Regarding to its internal structure, the placenta is classified in villous and labyrinthine; in 
the former, chorionic villi are present and they penetrate into uterine crypts; fetal blood is 
transported in vessels through these structures. In the labyrinthine placenta, maternal blood 
circulates through channels within the fetal syncytiotrophoblast.  
Histologically, the placenta is classified according to the layers between fetal and maternal 
blood, examined by light microscopy. The fetal components are endothelium, mesenchyma 
and trophoblast; maternal tissues are uterine epithelium, connective tissue and 
endothelium. When the uterine epithelium is in contact with the chorion (pig and horse) the 
placenta is called epitheliochorial; in ruminants, the uterine epithelium is removed and the 
maternal connective tissue is in contact with the chorion (Syndesmochorial placenta); 
uterine epithelium and connective tissue could be absent, and so the maternal endothelial 
basement membrane is in contact with the chorion, like in the carnivores placenta, and 
finally, in the haemochorial placenta, all the maternal tissue layers are removed, the chorion 
is in direct contact with the maternal circulation and such situation is observed in 
anthropoids and rodents. 
Some other criteria of classification have been proposed, like capillary position, regional 
specialization, tissue lost at parturition and accessory placental structures. For the classical 
criteria see (11) and for updates, see (6). 
2.3. Physiology 
The placenta is related to the production and metabolism of gonadotropins, steroids and 
prostaglandins hormones that are responsible for the pregnancy establishment and 
maintenance, placental maturation and parturition. Throughout gestation uterine 
environment shows great plasticity, which is necessary for fetal growth, being mediated by 
hormonal production of the placenta. This organ produces a great variety of hormones, 
including steroid hormones, peptides and insulin-like growth factors. In the human species, 
these factors are related to proliferation, invasion and differentiation of the trophoblast. 
Progesterone (P4) secretion in mammals is necessary to prepare the uterine environment to 
receive the developing conceptus. Embryonic signals, in the absence of P4, are inefficient to 
rescue the corpus luteum from the uterus luteolytic mechanisms, like in the ungulates, or to 
extend the luteal lifespan, as it occurs in the human species. In the ewe, hypophysectomy 
before day 50 of gestation causes corpus luteum regression and abortion. After this, the 
placenta produces P4 in sufficient concentrations to maintain pregnancy, even in the 
absence of ovaries and hypophysis.  
In ruminants, binucleate cells (BNC) are present in the trophoblast since the pre-
implantation period until parturition and these cells are found in the endometrium by day 
22 of pregnancy. BNC produce placental lactogen, P4, and prostaglandins E-2 and I-2. In the 
mare these cells produce the equine chorionic gonadotropin during their migration by the 
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uterine connective tissue. In the cow steroid production are altered throughout gestation. 
Two to three days before parturition, P4 levels decrease, and estradiol, in contrast, increase, 
and high levels are observed in the last week of gestation.  
BNC produce prostaglandins and it is possible that they are related to the maternal 
recognition of pregnancy in some species, like swine. It has been suggested that estrogens 
and prostaglandins have a physiological role in normal expulsion of the placenta in cattle.  
In the ruminant placenta, the trophoblast produces interferons that are responsible by the 
maternal recognition of pregnancy. Interferon tau has been recognized, in ungulates, as an 
inhibitor of luteolysis. Atypical interferons are produce by the swine blastocyst and its 
relationship with the maternal recognition of pregnancy is less clear. Type I interferons are 
produced by the human placenta and it is accepted that they are hormones related to the 
establishment of gestation in this species. For details see (12,13). 
3. In vitro culture of placental tissues 
3.1. Primary culture  
Basically the source of tissues to primary culture is human term placentas or animal 
placentas obtained in abattoirs. Cells can be obtained by mechanical disaggregation of 
placental tissues (amniochorion and allantochorion membranes, cotyledons, caruncles and 
the endometrium itself). Usually tissues are rinsed in Hank’s balanced salt solution (HBSS) 
or in phosphate-buffered saline (PBS) enriched with antibiotics (gentamicin, penicillin, 
streptomycin), to avoid bacterial contamination, and they are progressively dispersed with 
surgical scissors in at least six baths. After rinsed, tissues are cultured in suspension in 
Minimum Essential Medium (EMEM) with Earle’s salts. Disaggregate tissues contain 
different cell types and it may be necessary to go through a separation process. Amniocytes 
may be aspirated directly from placental fetal fluid and cultured in specialized medium 
such as Amniomax. These cells have adherent properties and form small aggregates in 
culture plastic flasks, being ideal for cariotypying. Basic culture conditions are 37º C and 5% 
CO2 atmosphere. Briefly, a protocol of cell separation is described. First, remove fat and 
dead tissues. Wash it with PBS twice. Slice placenta in trophoblast regions and transfer to a 
sterilized conical tube with cold PBS (10%) on ice. Release trophoblasts from chorionic villi 
by trypsin digestion. Plate the cells. Deplete macrophages by adherence to plastic. Freshly 
isolated cells are predominantly trophoblast villous that can be identified by verifying the 
expression of epidermal growth factor receptor (EGFR). Tissues and cells cultured primarily 
can be induced, by different ways, to produce proteins, hormones and other metabolites. 
The cell genome can be altered under experimental conditions in order to achieve research 
purposes, and different systems of tissue culture and cell manipulation could be assembly to 
diagnostic techniques and intracellular information flow investigation. 
Primary cultures are obtained by disaggregation of a tissue sample, either mechanically or 
enzymatically. The resulting suspension contains a proportion of cells capable of attaching 
to a surface, as in tissue culture flasks and dishes, forming a monolayer. Another type of cell 
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culture, the primary explants, consists of cells that migrate out from small fragments of 
tissue and adhere to the growth surface. Tissue disaggregation is capable of generating 
larger cultures in short periods of time, but explants culture may still be preferable where 
only small fragments of tissue are available or the fragility of the cells precludes survival 
after disaggregation.  
Generally, from human beings and large animals, placentae are obtained at term of normal 
pregnancies and after caesarean section or vaginal delivery. Amnion and chorion 
membranes are manually separated from each other. The membranes and other placental 
tissues as well, are washed extensively in PBS or HBSS containing 100 U/ml penicillin and 
100 µg/ml streptomycin to avoid bacterial contamination. Blood clots present in the 
cotyledons may be mechanically removed. 
In small animals like rats and mouse (Rattus norvegicus and Mus musculus), it is a common 
practice to excise the uteri from pregnant animals, transfer them to Petri dishes with cold 
PBS, and then, collect and pool the placentae in a new Petri dish. Harvested placentae are 
washed thoroughly with PBS containing antibiotics. Rat amnion may become 
distinguished as almost transparent, and may be peeled off from chorion and dissected 
(14). Otherwise, both membranes are processed together in order to obtain the fetal 
membrane-derived cells.   
Samples are cut into small fragments (3 x 3 or 5 x 5 cm) and may be stored in 50 ml vials 
filled with serum-free and phenol red-free Dulbecco’s Modified Eagle Medium (DMEM) in 
sterile conditions. The number of cells and their viability, either when stored at room 
temperature and processed within 24 hours or when stored at 4°C and processed within 28 
days, are the same as in fresh membranes, as previously reported (15,16). Those fragments 
may be either used as primary explants or submitted to enzymatic disaggregation. 
Small fragments of amniotic membrane may be directly engrafted to a site of injury, as focal 
ischemic regions in the heart, lung fibrosis, skin wounds, chronic leg ulcers, and liver fibrosis. 
The benefits of such therapeutic approaches as the ability to promote re-epithelialization have 
been shown to reduce inflammation and fibrosis and to modulate angiogenesis (16–19). 
Explants culture may also be done using fetal placental villi. Bundles of chorionic anchoring 
(stem) villi are separated from the chorionic plate and spread out using forceps to separate 
individual villi from each other. The villi are washed multiple times in PBS, cut into small 
pieces (1 x 1 mm) and cultured intact. When outgrowing cells reach 80% to 90% confluence, 
the villi pieces remaining intact are carefully removed, transferred into, and subsequently 
cultured on new plates to get a sufficient amount of cells for the experimental procedures. 
Recently it was reported that abundant vasculature present in the human placenta can serve 
as a source of myogenic cells able to migrate within dystrophic muscle and regenerate 
myofibers (20).  
Instead of using an entire fragment, fetal membranes may be subjected to enzymatic 
disaggregation, as reported in literature by various different protocols, which differ from 
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each other mainly regarding the enzyme employed and the digestion length. However, all 
of them include an incubation step at 37°C with some enzyme (dispase, trypsin/EDTA, 
collagenase) followed by collection of the cells through filtration and centrifugation. 
Different strategies employing diverse enzymes will be presented. Moreover, it is important 
to have in mind the kind of cells going to be isolated and the possibility of separating the 
fetal membranes. Chorion, cotyledons, and especially the amnion are rich sources of 
mesenchymal stromal/stem cells. The amnion is also comprised of an epithelial layer from 
which amnion epithelial cells are obtained. 
In order to isolate the amniotic mesenchymal stromal cells, first incubate membrane 
fragments with dispase (2.4 U/ml in PBS) for 9 minutes, followed by collagenase I (0.75 
mg/ml) + DNAse (20 µg/ml) solution in PBS for 150 minutes. An alternative option is only 
one digestion step using 1 mg/ml collagenase I for 120 minutes. Chorionic mesenchymal 
stromal cells may be isolated by performing two 9-minute dispase digestions, separated by 
one 9-minute wash step in RPMI-1640 containing 100 U/ml penicillin, 100 µg/ml 
streptomycin, and 10% heat-inactivated fetal bovine serum (FBS). Another way is to replace 
the dispase of the first digestion step by collagenase IV. After gentle centrifugation (150 x g 
for 3 minutes), filtrate each supernatant containing amniotic or chorionic mesenchymal 
stromal cells in a 100 µm cell strainer. However, mesenchymal stromal cells may be isolated 
from the placenta without previously separation of its components. In such situation, mince 
pieces from fetal membranes and incubate for 10 minutes in DMEM with 0.25% 
trypsin/EDTA, 10 U/ml DNase I, and 0.1% collagenase. Tissues should be pipetted 
vigorously up and down, avoiding foam, for 5 minutes. Allow large pieces of tissue to settle 
under gravity for 5 minutes. Transfer the supernatant to a fresh tube, neutralize with FBS, 
and then spin at 1500 rpm for 10 minutes. 
Amniotic undigested pieces (when amnion is incubated either with dispase and collagenase 
I or collagenase I only, as previously described) may be submitted to another digestion step 
with trypsin (0.25% in PBS) for 2 minutes, in order to obtain epithelial cells. 
Moreover, epithelial cells may be harvested from amniotic membrane fragments after 
digestion only with trypsin/EDTA, at 37°C. One way is to use the enzyme at 0.125% and 
incubate three times at 20 minutes each. Alternatively, two digestion steps of 30 minutes 
each, shaking (0.20% trypsin/EDTA) or two steps of 20 minutes (0.25% trypsin/EDTA) are 
considered. Trypsin should be inactivated by adding FBS. Collect the cells after 
centrifugation (1000 rpm for 5 minutes). It is important to highlight that, in all situations, the 
amniotic epithelial cell layer must be scraped out to remove the underlying tissues, such as 
the spongy and fibroblast layers, to obtain a pure epithelial layer. 
In addition to all disaggregation protocols for amniotic membrane, to achieve different 
populations of cells (amniotic mesenchymal stromal and amniotic epithelial), the whole 
membrane may be digested giving a mix of cells, known as amniotic derived cells. 
Membrane fragments are digested with 0.25% trypsin/EDTA for 30 minutes at 37°C. Cells 
are collected after filtration in 100 µm cell strainer and three wash steps in cold PBS. 
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Another protocol requires three digestion steps (1x15 minutes; 2x30 minutes) in 0.05% 
trypsin at 37°C. Wash cells three times in PBS and collect after centrifugation (1000 rpm for 5 
minutes). 
Another placental tissue used for cell isolation is cotyledon. Minced cotyledon is digested 
with 0.25% trypsin for 60 minutes at 37°C. Incubate the undigested fragments with 12.5 
U/ml collagenase I for 60 minutes at 37°C. Collect cells by filtration (100 µm cell strainer) 
and centrifugation (300 x g for 10 minutes).    
Finally, when fetal membranes are difficult to distinguish (i.e. small animals as mouse) 
incubate the placenta with dispase (2.4 U/ml in PBS) for 5 minutes at 37°C, followed by 
collagenase (0.75 mg/ml) + DNAse (20 µg/ml) in PBS for 90 minutes at 37°C. After filtration 
(100 µm cell strainer) and centrifugation (300 x g for 5 minutes) a mix of amniotic and 
chorionic cells are obtained. Alternatively, digest placenta fragments with 300 U/ml 
collagenase II for 1 hour at 37°C in water shaker. Neutralize enzyme activity with ɑ-minimal 
essential medium (ɑ-MEM) containing 10% FBS. Collect the cells after filtration and 
centrifugation. 
Cells obtained after any of the procedures mentioned above must be plate onto noncoated 
tissue culture dishes or flasks. Cells may be seeded at 7x103/cm2 (amniotic mesenchymal 
stromal cells) and 14-21x103/cm2 (amniotic epithelial cells). The medium should be 
supplemented with serum, mainly FBS. There is a common practice, in some research 
centers, to use 20% of serum for the primary culture, and then, replace it for 10% in further 
passages. However, such cells are perfectly capable to survive and proliferate when incubate 
with 10% serum from the first passage. The most commonly used media are Roswell Park 
Memorial Institute (RPMI)-1640, DMEM, ɑ-MEM, and DMEM/F12. It is also important to 
supplement the medium with antibiotics (100 U/ml penicillin and 100 µg/ml streptomycin or 
1% antibiotic-antimycotic solution), L-glutamine (2 mM), nonessential amino acids (1%), β-
mercaptoethanol (55 µM), and sodium pyruvate (1 mM). Cells are incubated at 37°C in a 
humid atmosphere (5% CO2).  
Morphological characterization of the cells, by light microscopy, indicates that amniotic 
epithelial cells show ground or oval shapes, cluster formation, relatively big nucleus (some 
can reach half of the cell diameter) and many fat drops in the cytoplasm. Both amniotic and 
chorionic mesenchymal stromal cells show the fibroblast-like appearance and very high 
proliferation rate, reaching 70-80% confluence after one to three weeks from harvesting.  
Cells may either be used in experimental procedures just right after culturing or be frozen 
in 10% dimethyl sulfoxide (DMSO) and 90% FBS. An alternative freezing media is 10% 
DMSO, 40% DMEM, 50% FBS. Prior to using these cells, it is recommended to analyze the 
viability, which may be determined by use of trypan blue dye, and cell number in a 
hemocytometer. 
In addition, it is important to highlight that all experimental procedures must have ethics 
committee’s approval and, regarding human placental tissues, the previous donor consent. 
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3.2. Established (transformed) cell lines 
There are a lot of cell lines derived from placenta. These cells are cultured with subtle 
differences, for research purposes and some of them are able to secret hormones and other 
molecules. Some examples will be present.  
BeWo (ATCC® number CCL-98™) is a human epithelial cell line, derived from 
choriocarcinoma, that produces progesterone, human chorionic gonadotropin (hCG), 
placental lactogen, estrogen and other reproductive hormones. BeWo is cultured in F-12K 
medium enriched with 10% FBS. This cell is sensible to human poliovirus 3 and the 
vesicular stomatitis virus. Other human epithelial cell lines derived from choriocarcinoma 
are JEG-3 (ATCC® number HTB-36™) and JAR (ATCC® number HTB-144™). JEG-3 
produces hCG, progesterone and placental lactogen. The cells are able to transform steroid 
precursors to estrone and estradiol. The line is cultured with EMEM supplemented with 
10% FBS. JAR cells produce estrogen, progesterone, hCG, and placental lactogen and are 
cultured in RPMI 1640 supplemented with 10% FBS.   
The M. musculus mast cells 10P2 (ATCC® number CRL-2034™) and 10P12 (ATCC® number 
CRL-2036™) were established by transformation of placental cells from a 10 day mouse 
embryo, and are cultured in suspension with RPMI 1640 medium supplemented with 0.05 
mM 2-mercaptoethanol and 10% FBS. These cells possess receptors for IgE. Both lines 
represent a transformed stage of a very early hematopoietic precursor and share surface 
antigens with multipotent stem cells. The 11P0-1 (ATCC® number CRL-2037™) cell line is 
similar with the others except for being derived from a 11 day mouse embryo. 
The FC-47 (ATCC® number CRL-6094™) is a fibroblast derived from the cat (Felis catus) 
normal placenta, with adherent properties and cultured in DMEM supplemented with 10% 
FBS. 
The 3A-(tPA-30-1) (ATCC® number CRL-1583™) is a human SV40 transformed cell line, 
derived from placenta, showing an epithelial morphology. When incubate at 40°C, these 
cells are able to synthesize hCG and alkaline phosphatase. The cells express the transformed 
phenotype at the permissive temperature (33°C) and the non- transformed phenotype at the 
non- permissive temperature (40°C). The line has a limited life expectancy of 15 to 18 
passages before entering the crisis stage. Medium required for incubation is ɑ-MEM 
supplemented with 10% FBS. 
ChaGo-K-1 (ATCC® number HTB-168™) is a human epithelial cell line, derived from 
bronchogenic carcinoma, that produces hCG alpha subunit only, estradiol, progesterone, 
and mucin (apomucin, MUC-1, MUC-2). The cells are cultured in RPMI 1640 supplemented 
with 10% FBS. 
There are several cell lines derived from normal human placenta, which are available for 
research purposes, such as Hs 726.PI (ATCC® number CRL-7460™), Hs 730.PI (ATCC® 
number CRL-7464™), Hs 795.PI (ATCC® number CRL-7526™), Hs 798.PI (ATCC® number 
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CRL-7529™), Hs 799.PI (ATCC® number CRL-7530™), Hs 815.PI (ATCC® number CRL-
7548™). All of them are cultured in DMEM supplemented with 10% FBS, at 37°C, in 
humidity atmosphere (5% CO2).  
3.3. Placenta-derived stem/progenitor cells 
Various undifferentiated stem cell sources have been proposed for regenerative medicine, 
each having their advantages and drawbacks. Embryonic stem cells (ESCs) are characterized 
by pluripotency and an unlimited self-renewal capacity, but they may present high 
tumorigenic potential and their use is associated with major ethical concerns. In contrast, 
mesenchymal stem cells (MSCs) are not ethically restricted, but show limited capacity to 
proliferate and differentiate into different cell lineages (multipotency). MSCs reside within 
bone marrow, adipose tissue, dental pulp, and many other tissues. Although bone marrow 
MSCs are the most studied and the best established, there are some limitations of their use 
due to invasive nature of bone marrow aspiration, donor site morbidity, inadequate cell 
numbers, and the limited capacity of proliferation and differentiation. Thus, researchers 
started looking for alternative sources of MSCs that can be obtained noninvasively and in 
sufficient quantity. Studies have shown that MSCs may be isolated from placenta (either 
from maternal or fetal components, especially from the amnion), which are generally 
discarded as medical waste after delivery, and are therefore without ethical concerns 
associated with their use. Placenta-derived MSCs have been described to combine 
characteristics from both embryonic and mesenchymal stem cells: the ability to differentiate 
into all three germ layers and lack of tumorigenicity. Although specific fetal membrane 
components have already been considered in the above section “primary culture” of this 
chapter, here aspects of placenta MSCs will be discussed, without distinction between any 
fetal membranes as a specific source of cells, even though the amniotic MSCs are the most 
studied. It should be highlighted that efforts toward standardization of the terminologies 
used have been made (21) in the First International Workshop on placenta-derived stem 
cells, who proposed the following nomenclature: aminiotic epithelial cells, aminiotic 
mesenchymal stromal cells, chorionic mesenchymal stromal cells, and chorionic 
trophoblastic cells. 
One way to identify a population of cells is by performing its immunophenotype 
characterization, mainly for surface marker expression. Current methodologies employed 
are immunocytochemistry, immunofluorescence, and flow cytometry. Placenta MSCs 
reveal profiles in between embryonic and adult stem cells, as summarized in Table 1 
where it is shown some of the most used surface markers, as cluster of differentiation 
(CD), for categorizing stem cell populations. It is important to note that neither embryonic 
nor mesenchymal cells (and placenta-derived MSC as well) express the hematopoietic 
stem cell markers CD11b, CD34, and CD45. Placenta MSCs show a positive expression 
profile for CD29, CD73, CD166, and major histocompatibility complex (MHC) class I 
molecules (human leucocyte antigen (HLA) -A, -B, -C) and a negative expression profile 
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for CD11b, CD31 (endothelial marker), CD34, CD45, and MHC class II molecules (HLA-
DR, -DP, -DQ).  
Although there are common properties between placenta and bone marrow derived MSCs, 
flow cytometric analyses performed by different research groups report that placenta MSCs 
do not express CD271 (22) and show different patterns for CD90 expression: either low 
[4.7% (14)], moderate [22.5% (23)], or high expression [> 95% (22)] and even the presence of 
two distinct subpopulations of placenta MSCs positive for CD90 (24). 
Taken together, placenta MSCs satisfy the minimal criteria for identifying multipotent 
mesenchymal stromal cells (27). Furthermore placenta MSCs, different from other 
mesenchymal cells, are able to differentiate into ectodermal (neural and retinal cells), 
endodermal (pancreatic beta cells), and mesodermal (adipocytes, osteocytes, and 
chondrocytes along with myotubule formation and endothelial cells) lineages in vitro 
(24,25). 
Moreover, placenta MSCs are positive for surface markers that are expressed by embryonic 
stem cells but not by mesenchymal cells. Among them are octamer binding protein 4 (Oct-4), 
Sox2, Nanog, stage-specific embryonic antigen (SSEA)-1, SSEA-4, GCTM2, Tra-1-60, and 
Tra-1-80 which are routinely evaluated by immunocytochemistry or flow cytometry 
(14,23,26). Even when analyzing such expression using more sensitive assays, as in real time 
polymerase chain reaction (q-PCR), it is observed that placenta MSCs significantly express 
high levels of Oct-4, Nanog and Sox2 (25). In addition, it was detected by 
immunofluorescence analysis that human amniotic stem cells, different from other MSCs, 
are positive for the neural stem cell markers Nestin, Vimentin, Musashi-1, and PSA-NCAM 
(28). However, all of these data should be analyzed carefully. Some studies indicate variable 
percentages of positive cells for different pluripotent markers, indicating that more studies 
are need.  
Besides the pluripotency potential of placenta MSCs and the lack of ethical concerns, an 
important characteristic that lead placenta MSCs to a great importance for clinical 
application is their low immunogenicity. This property is partially explained by the fact that 
placenta MSCs do not express MHC class II molecules (HLA-DR, -DP, -DQ) and co-
stimulatory molecules in vitro, as reported by different research groups and using different 
methodologies (flow cytometry, qPCR, western blotting), indicating that such cells can be 
effectively used for both autologous and allogenic transplantations. It was recently 
demonstrated that fetal membrane MSCs are capable of suppressing proliferation in a mix 
lymphocyte reaction, decreasing interferon (IFN)-ɣ and interleukin (IL)-17 production, 
stimulating IL-10 secretion, and increasing levels of adhesion markers CD54, CD29, and 
CD49d (29). In addition, placenta MSCs are able to engraft and survive long-term in various 
organs and tissues without evidence of inflammation or rejection after transplantation into 
neonatal animals and after in utero transplantation into pregnant rats (30,31). Therefore, 
placenta MSCs are viable candidates for cell-based therapeutic approaches.  
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Surface marker Cell types References 
 ESC MSC Placenta – MSC  
CD11b - - - (24) 
CD34 - - - (14,22–27) 
CD45 - - - (14,22–24,26,27) 
CD29 - + + (14,22,24–27) 
CD73 - + + (22–26) 
CD90 - + ND (14,22–25,27) 
CD105 - + - (23,25,27) 
CD166 - + + (23,26) 
CD271 - + - (22) 
Nanog + - + (25,26) 
Oct-4 + - + (14,23,25,26) 
Sox-2 + - + (23,25,26) 
SSEA-1 + - + (14) 
SSEA-4 + - + (23,26) 
GCTM-2 + - + (23,26) 
Tra-1-60 + - + (26) 
Tra-1-80 + - + (26) 
(+): presence; (-): absence; ND: not defined 
Table 1. Surface marker expression from embryonic stem cells (ESC), adult mesenchymal stem cells 
(MSC), and placenta derived mesenchymal stem cells (placenta-MSC). 
When considering cellular therapy it is important to keep in mind that a great number of 
cells will be needed and cell banking may be required. As a result, it is imperative that cells 
possess some important characteristics: abundant source, high proliferation rate, stability 
over further passages, efficient freezing, and high viability after thawing. Placenta MSCs 
have been demonstrated to fulfill such requirements. It was recently reported that placenta 
MSCs at passage 30 are still able to proliferate in normal rates and keep a stable karyotype 
(25). Such characteristics are observed in ESCs but not in other types of MSCs, such as those 
derived from bone marrow or adipose tissue, which don’t proliferate well and go to 
senescence around passages 8-10. Compared to ESCs, MSCs are more resistant to 
cryopreservation. Whilst ESCs require complex and expansive reagents to be frozen and 
great number of cells die, placenta MSCs are successfully frozen in 40% DMEM, 50% FBS, 
10% DMSO, as well as bone marrow and adipose tissue MSCs, with high recovery rates after 
thawing. Among many different assays to evaluate cellular viability, the measurement of 
mitochondrial metabolic rate using MTT (3-[4, 5-dimethyl-2-thiazolyl]-2, 5-diphenyl-2H-
tetrazolium bromide) to indirectly reflect viable cell numbers has been widely applied. 
However, if the purpose is to evaluate the viability and the number of cells immediately 
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before their transplantation to human or animals, trypan blue dye exclusion assay is 
preferable because only the unavailable cells are dyed, while the desired cells are 
maintained viable, ready to use. 
Before considering using placenta MSCs for clinical purposes, preclinical studies may be 
performed and the results must be carefully interpreted in order to assure safety for the 
patient and success in the therapy. Many preclinical studies on placenta-derived cells and 
amniotic membrane were reviewed (32), considering a wide range of diseases as 
neurological, pancreatic, muscle, vascular, cardiac, and pulmonary disorders along with 
liver fibrosis and applications for tissue engineering. Overall the results are promising 
and, although differentiation of placenta MSCs to specific lineages has been considered 
the first necessity for therapeutic applications in vivo, it seems that the beneficial effects 
reside on paracrine effects. However, both mechanisms (differentiation or paracrine) are 
not mutually exclusive and can account for the promising results reported in the 
literature.  
As placenta MSCs share with ESCs some common characteristics such as surface marker 
expression and plasticity in vitro, it was assumed that placenta cells could regenerate 
damaged tissues due to pluripotency potential. To date, however, preclinical studies have 
failed to demonstrate the differentiation of engrafted cells. Most of the time the success of 
the cell transplantation may more likely be due to the secretion of bioactive molecules that 
could act on other cells and on the microenvironment which they occupy thereby promoting 
endogenous tissue repair or eliciting other beneficial effects (anti-inflammatory, anti-
scarring, angiogenic effects) through paracrine actions.  
The abundance of pluripotent cells, high yield, rapid proliferation rates, stable karyotype, 
plasticity and immunomodulatory properties make placenta MSCs an ideal choice for 
clinical and tissue engineering applications. Nevertheless, further studies are needed to 
demonstrate the pluripotency ability of placenta MSCs in vivo and to elucidate the 
mechanisms by which these cells promote physiological and clinical improvements.  
4. Conclusion 
Eutherian mammalian fetus growth is characterized by the early development of fetal 
membranes, specially the trophoblast, which produces hormones for the establishment, 
maintenance and end of pregnancy. The fetomaternal interface varies among species and is 
a basis for placental structure classification. Primary cultures from placenta are obtained in 
an easy and not consuming fashion allowing a great number of research applications. 
Various undifferentiated stem cell sources have been proposed for regenerative medicine. In 
this setting placenta-derived cells show some advantages as potential to differentiate into 
the three germ layers, lack of tumorigenicity, low immunogenicity, and more importantly 
that they are isolated in high yields from sources generally considered medical waste, 
avoiding ethical concerns. 
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